Page last updated: 2024-12-11

plicatin b acrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

plicatin B acrylate: isolated from the medicinal plants Psoralea juncaea and P. plicata; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
PsoraleagenusA plant genus of the family FABACEAE that is a source of psoralen (FICUSIN).[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID6438704
CHEMBL ID451699
SCHEMBL ID1227605
MeSH IDM0258738

Synonyms (12)

Synonym
plicatin b
CHEMBL451699
methyl (e)-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-enoate
methyl (e)-3-(4-hydroxy-3-(3-methyl-2-butenyl)phenyl)-2-propenoate
72704-01-9
plicatin b acrylate
2-propenoic acid, 3-(4-hydroxy-3-(3-methyl-2-butenyl)phenyl)-, methyl ester, (e)-
methyl 3-(4-hydroxy-3-(3-methyl-2-butenyl)phenyl)-2-propenoate
SCHEMBL1227605
LZEOAWXRNGQEHO-RMKNXTFCSA-N
Q7204957
DTXSID801029774
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID614378Modulation of HIF1 expressed in HEK293 cells assessed as luciferase activity under hypoxic condition at 50 uM after 24 hrs by luminometer analysis relative to hypoxic control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis.
AID614387Cytotoxicity against human HCT116 cells assessed as cell viability under normoxic condition after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis.
AID377976Antimutagenic activity in Salmonella Typhimurium TA100 assessed as inhibition of ethyl methanesulfonate-induced mutation at 7.8 uM treated for 30 mins and measured after 2 days by modified Ames test1999Journal of natural products, Jan, Volume: 62, Issue:1
Structure-antimutagenic activity relationship study of plicatin B.
AID377975Antimutagenic activity in Salmonella Typhimurium TA100 assessed as inhibition of ethyl methanesulfonate-induced mutation at 3.9 uM treated for 30 mins and measured after 2 days by modified Ames test1999Journal of natural products, Jan, Volume: 62, Issue:1
Structure-antimutagenic activity relationship study of plicatin B.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's5 (62.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.36 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]